Neumora Therapeutics

About

Neumora Therapeutics operates as a clinical-stage biotechnology company.

Watertown,Massachusetts,United States
10001 - max

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $112M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2019
Number Of Employee: 10001 - max
Operating Status: Active

Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$612M

Neumora Therapeutics has raised a total of $612M in funding over 2 rounds. Their latest funding was raised on Oct 11, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 11, 2022	Series B	$112M	10	Mubadala Capital Ventures	—	Detail
Oct 7, 2021	Series A	$400M	14	ARCH Venture Partners	—	Detail
Oct 7, 2021	Corporate Round	$100M	1	Amgen	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

17

Neumora Therapeutics is funded by 17 investors. Mubadala Capital Ventures and ARCH Venture Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Mubadala Capital Ventures	Yes	Series B
ARCH Venture Partners	—	Series B
Abu Dhabi Growth Fund	—	Series B
Altitude Life Science Ventures	—	Series B
Amgen	—	Series B
EXOR N.V.	—	Series B
F-Prime Capital	—	Series B
Invus	—	Series B
Newpath Management	—	Series B
Polaris Partners	—	Series B